SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SARS and Avian Flu
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (76)4/11/2003 11:05:31 AM
From: scaram(o)uche  Read Replies (1) of 4232
 
mixed sentiments..... ADVR has been a trader pump and dump tool since at least 1994. OTOH, the business plan has a large element of "a Hybridon" or "a Coley" in it...... super echinacea. IMO, much preferable to the old Alpha Beta Technology (Technologies?), which achieved an enormous market cap with a yeast extract that purportedly reacted with mannan receptors and stimulated macrophages.

There are many bioterror bucks going to this sort of work. One should remember that a little bit of a toxic molecule from Gram negative bacteria provides tolerance to subsequent exposures, that you can protect from bad stuff with a little bit of it. There's reason to be enthusiastic, to a limited degree, about the potential for a kick in the butt from innate immunity.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News